Memory & Dementia Flashcards

1
Q

What is learning?

A

The acquisition of new information or knowledge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is memory?

A

The storage or retention of acquired knowledge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an engram?

A

The physical representation or location of a memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two main types of long-term memory?

A
  1. Declarative (explicit)
  2. Non-declarative (implicit)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What brain regions are involved in non-declarative memory? (3)

A
  • The cerebellum
  • Amygdala
  • Striatum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What brain regions are involved in declarative memory? (3)

A
  • The cerebellum
  • Entorhinal cortex
  • Parahippocampal cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Hebb’s Law?

A

“Cells that fire together, wire together” - simultaneous activity strengthens synaptic connections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Long-Term Potentiation (LTP)

A

A key process in memory formation involving NMDA receptor activation and calcium influx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What changes occur at the synapse during LTP? (2)

A

Presynaptic: Increased glutamate release.

Postsynaptic: Increased AMPA receptor numbers and dendritic spine growth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two types of amnesia?

A
  1. Retrograde amnesia (loss of past memories).
  2. Anteretrograde amnesia (inability to form new memories.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is dementia?

A

A syndrome characterised by cognitive decline that impairs social or occupational functioning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the most common type of dementia?

A

Alzheimer’s Disease (AD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the main pathological features of Alzheimer’s Disease? (2)

A
  • Neuritic plaques: Extracellular deposits of amyloid-β protein.
  • Neurofibrillary tangles (NFTs): Intracellular tau protein accumulation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does amyloid-β contribute to neuronal death in AD?

A

Aggregates with metal ions to produce H₂O₂ causing oxidative stress and excessive Ca²⁺ influx.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the main symptomatic treatments for Alzheimer’s Disease?

A
  • Cholinesterase inhibitors (e.g., Donepezil, Rivastigmine).
  • Memantine: NMDA receptor blocker.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are experimental treatments for Alzheimer’s Disease? (4)

A
  • Secretase inhibitors
  • Anti-amyloid and anti-tau vaccines.
  • Copper/zinc chelators.
  • Antioxidants
17
Q

What is the role of cholinesterase inhibitors in AD?

A

Enhance acetylcholine activity, providing small cognitive benefits.

18
Q

What are AMPAkines and how do they work?

A

Drugs that enhance AMPA receptor activity, potentially improving cognitive function.

19
Q

What are the key risk factors for dementia? (4)

A
  • Aging
  • Genetic predisposition
  • Cardiovascular risk factors
  • Head trauma
20
Q

What is the main focus of future Alzheimer’s research? (2)

A
  • Early diagnosis through biomarkers
  • Monoclonal antibodies (e.g., Donanemab, Lecanemab)
21
Q

How does Memantine work in Alzheimer’s disease?

A

It is an NMDA receptor blocker that reduces excitotoxicity and may provide neuroprotection.

22
Q

What are secretase inhibitors, and how might they help in AD?

A

Drugs that block β- or γ-secretase to reduce amyloid-beta production.